All for good medicine, all for mankind’s health

READ DETAILS
VALUES

TECHNICAL RESEARCH AND DEVELOPMENT

CSPC’s R&D is being conducted in China and America at the same time and a global collaborative open research and development system has been established...

READ DETAILS
R&D

CSPC GLOBALLY

CSPC is listed in Top 10 Asian Pharmaceutical Companiesin Sales Revenue, and its products are sold throughout China and more than 60 countries and regions in the world. In 2018, Institutional Investor, an international authoritative financial magazine, presented the latest annual ranking list in which CSPC was awarded The Most Respected Enterprise in the rating of Company Management Team in Asia 2018. In 2017, the total export value reached to USD 600 million and CSPC ranked first among...

READ DETAILS

CSPC IN CHINA

CSPC has a total asset of RMB 41 billion and around 25,000 employees up to now. Listed in Hong Kong(01093.HK)with market value of more than HK$ 100 billion and being one of the Hang Seng Index constituent stocks, CSPC has been the first pharmaceutical share since the past 50 years
As the Chinese leading pharmaceutical enterprise ,CSPC is engaged in development, production and sale.The key products include seven branches and nearly 1,000 varieties...

READ DETAILS

2017 annual company report

For the year ended 31 December 2017, the Group recorded turnover of approximately HK$15,463 million, representing a 25.0% growth (or a 26.6% growth on a constant currency basis) year-on-year; and profit attributable to shareholders of approximately ...

READ DETAILS